Close this search box.


These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.

Medline Title Search (Dupuytren + (inflammation OR inflammatory))

Selected Publications

  • Józsa L, Salamon A, Réffy A, Renner A, Demel S, Donhöffer A, et al. Fine structural alterations of the palmar aponeurosis in Dupuytren’s contracture. A combined scanning and transmission electron microscopic examination. Zentralbl Allg Pathol. 1988/01/01 ed. 1988 Jan;134(1):15–25. (PDF)
  • Mayerl C, Del Frari B, Parson W, Boeck G, Piza-Katzer H, Wick G, et al. Characterisation of the inflammatory response in Dupuytren’s disease. J Plast Surg Hand Surg. 2016;6764(February):1–9. (PDF)
  • Paulis G. (2012). “Inflammatory Mechanisms and Oxidative Stress in Peyronie’s Disease: Therapeutic “Rationale“ and Related Emerging Treatment Strategies.” Inflammation & Allergy – Drug Targets. (PDF)
  • Bianchi Enrica, Taurone Samanta, et al. (2015). “Involvement of pro-Inflammatory Cytokines and Growth Factors in the Pathogenesis of Dupuytren’s Contracture: A Novel Target for a Possible Future Therapeutic Strategy?” Clinical Science 129 (8): 711–20. (PDF)
  • Bujak Maro, Ratkaj Ivana, Markova-Car Elitza, Jurišić Davor, Horvatić Anita, Vučinić Srđan, Lerga Jonatan, Baus-Lončar Mirela, Pavelić Krešimir, Kraljević Pavelić Sandra. (2015). “Inflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren’s Disease Fibroblasts.” Frontiers in Molecular Biosciences 2 (December): 1–9. (PDF)
  • Andrew JG, Andrew SM, Ash A, Turner B. (1991). “An Investigation into the Role of Inflammatory Cells in Dupuytren’s Disease.” Journal of Hand Surgery (Edinburgh, Scotland) 16 (3): 267–71. (PDF)
  • Qureshi FI, Hornigold R, Spencer JD, Hall SM. (2001). “Langerhans Cells in Dupuytren’s Contracture.” J Hand Surg Br 26 (4): 362–67. (PDF)
  • Verjee LS, Verhoekx JS, Chan JK, Krausgruber T, Nicolaidou V, Izadi D, Davidson D, Feldmann M, Midwood KS, Nanchahal J. (2013). “Unraveling the Signaling Pathways Promoting Fibrosis in Dupuytren’s Disease Reveals TNF as a Therapeutic Target.” Proc Natl Acad Sci U S A 110 (10): E928-37. (PDF)